February 10, 2017Scanogen receives a new grant for $3 million from the NIH to develop a rapid assay for Tuberculosis detection.
July 5, 2016Scanogen is granted two U.S. patents for inventions that use DNA supercoiling to detect biomolecules. describes circular biosensors that compact when target molecules are present in the sample. describes Twist-Biosensor, a single molecule approach in which DNA tethered beads are displaced when target molecules are present in the sample.
June 20, 2016A patent is filed with the U.S. Patent Office to protect the imaging system used by the Scanogen instrument.
February 1, 2016Scanogen moves to new facilities. The new space has renovated laboratories and offices, with a total area of 4,000 sq ft.
October 1, 2015Scanogen TB assay is described in the . “In the context of limited-resource setting TB diagnosis, Single Molecule Scanning may offer important advantages over the available amplification-based molecular platforms.”
May 15, 2014Scanogen receives two new SBIR grants, from the , and the .
February 6, 2014An international PCT patent is filed to protect the Single Molecule Scanning technique.
September 24, 2013A U.S. Patent is filed to protect an alternative method to use the Twist-Biosensor.
September 19, 2013Scanogen receives grant from the of the .
January 16, 2013Scanogen receives phase I SBIR grant from the .
October 10, 2012An international PCT patent is filed to protect the invention of the Twist-Biosensor.
October 31, 2011Scanogen is funded and registered to operate in Maryland.
| © 2016 Scanogen Inc.
3102 Lord Baltimore Dr., Suite 214, Baltimore, MD, 21244 | email@example.com